Inventprise Inc.
Inventprise Inc.
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults | Bacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, bacterial infectious disease, diarrheal disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosis | Recruiting | Phase 1 | 2025-11-19 | NCT07205926 | |
| Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age. | Bacterial Infections and Mycoses, Group B Streptococcal Infections, Infections, bacterial infectious disease, gram-positive bacterial infections, streptococcal infection | Active, not recruiting | Phase 1 / Phase 2 | 2025-11-18 | NCT06611371 | |
| Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, pneumococcal infection, streptococcal infection | Active, not recruiting | Phase 2 | 2025-09-02 | NCT06790290 |